Brief: Atossa Therapeutics Announces Second Quarter 2022 Financial Results And Provides Corporate Update
08/08/2022 23:38
Atossa Therapeutics Inc ATOS.O :
* ATOSSA THERAPEUTICS ANNOUNCES SECOND QUARTER 2022
FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE
* ATOSSA THERAPEUTICS - FOR QUARTER ENDED JUNE 30, 2022,
ATOSSA
HAD NO SOURCE OF SUSTAINABLE REVENUE AND NO ASSOCIATED COST OF
REVENUE
* ATOSSA THERAPEUTICS - QTRLY LOSS PER SHARE $0.05
Source text for Eikon: ID:nGNX7k59R1
Further company coverage: ATOS.O
Recent news on Atossa Therapeutics
See all newsAtossa Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary
Atossa Therapeutics Q3 net loss narrows as clinical trial expenses decline
Brief: Atossa Therapeutics Executes Contingent Value Rights Agreement Providing Shareholders Participation In Potential Priority Review Voucher Value
US RESEARCH ROUNDUP-Amrize, Dexcom, Lennar
Atossa Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary